Recro pharma, inc. (REPH)
CashFlow / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14
Schedule Of Defined Benefit Plans Disclosures [Table]
Defined Benefit Plan Disclosure [Line Items]
Cash flows from operating activities, continuing operations:
Net loss

-7,692

-9,509

-4,307

-2,837

-1,977

-41,297

-13,254

-12,717

-12,455

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss on discontinued operations

-

-

-

-

-2,173

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net loss

-

-

-

-

-

-

-

-

-

-

-

-

-8,087

-10,402

-5,379

-7,885

-6,539

-

-

-

-

-

-

-

-

Adjustments to reconcile net income (loss) from continuing operations to net cash provided by operating activities from continuing operations:
Net loss

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-4,136

-3,480

-4,713

-2,793

-5,146

Stock-based compensation

3,231

-735

1,741

3,371

1,814

-971

1,947

1,719

1,584

-87

1,895

1,478

892

1,090

1,369

729

701

1,339

988

504

232

201

155

155

19

Non-cash interest expense

1,460

1,540

1,458

1,397

1,017

319

329

320

319

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Non-cash interest expense

-

-

-

-

-

-

-

-

-

-

-

-

158

271

351

153

296

-

-

-

-

-

-

-

-

Depreciation expense

1,500

1,161

1,626

1,713

1,317

1,053

1,321

1,282

1,216

1,138

1,231

1,228

1,196

1,237

1,245

1,240

1,271

-

-

-

-

-

-

-

-

Amortization of intangible assets

646

645

646

646

646

645

646

646

646

646

645

646

646

646

646

645

646

-

-

-

-

-

-

-

-

Noncash interest expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

4,272

Change in warrant valuation

-

1,177

160

1,042

-263

362

287

-1,138

773

-6

808

-1,084

291

-420

401

1,240

-1,594

-

-

-

-

-

-

-

-

Change in contingent consideration valuation

-

-

-

-

-

-

4,114

396

2,520

-

3,550

2,959

2,814

2,023

3,193

1,534

2,978

-

-

-

-

-

-

-

-

Deferred income taxes

-

-

-

-

-

-25,067

2,370

2,707

2,353

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Changes in operating assets and liabilities:
Deferred income taxes

-

-

-

-

-

-

-

-

-

-

-

-

-1,235

-1,071

655

-601

-406

-

-

-

-

-

-

-

-

Inventory

-3,028

2,150

3,283

-529

-531

517

2,069

-1,915

189

-53

3,004

-922

-936

-1,067

3,084

-910

-1,344

-

-

-

-

-

-

-

-

Contract asset

901

-1,792

2,489

3,046

-93

-2,264

599

1,358

1,753

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Prepaid expenses and other current assets

-1,078

988

-1,724

648

692

678

-187

929

-912

-1,424

213

936

518

-586

-187

921

177

-

-

-

-

-

-

-

-

Right-of-use asset

-47

293

-161

-284

-55

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accounts receivable

97

-1,828

-1,579

1,578

3,352

1,121

74

1,838

147

-3,440

3,024

-2,176

1,867

-2,013

957

-702

3,589

-

-

-

-

-

-

-

-

Accounts payable, accrued expenses and other liabilities

1,286

5,996

1,996

-8,757

401

1,334

-1,287

4,965

-5,870

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Operating lease liability

-48

293

-163

-287

-56

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash used in operating activities

-

-

-

-

-

-

-10,822

-9,444

-14,797

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Prepaid expenses

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-21

890

-394

467

-136

-17

271

Other receivables

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-9

2

86

-35

-2

Accounts payable and accrued expenses

-

-

-

-

-

-

-

-

-

-

-

-

-2,363

-

-

-

2,624

-

-1,358

3,513

532

-468

580

681

306

Net cash provided by operating activities, continuing operations

3,538

-

-

-

1,707

-

-

-

-

-

-

-

-7,137

996

1,197

-2,950

-2,445

619

6,139

4,666

-2,966

-4,218

-3,928

-1,903

-815

Cash flows from investing activities, continuing operations:
Purchases of property and equipment

620

-1,301

535

6,459

2,649

2,835

1,432

1,277

1,654

817

1,401

1,441

1,744

1,756

933

737

344

-

-

-

-

-

-

-

-

Purchases of short-term investments

-

80

-1

0

12,021

0

1,243

1

4,981

1,498

2,033

17,476

36,117

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from maturity of investments

-

-

-

-

-

1,250

0

5,000

3,500

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash (used in)/provided by investing activities

-

-

-

-

-

-

-2,675

3,640

-3,135

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash used in investing activities, continuing operations

-620

-

-

-

-14,670

-

-

-

-

-

-

-

-37,861

-1,756

-933

-737

-344

-

-

-

-

-

-

-

-

Cash flows from financing activities, continuing operations:
Proceeds from initial public offering

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-168

30,533

Proceeds from Aspire facility

-

-

-

-

-

-

-

-

-

-

-

-

-

3,621

0

3,615

560

-

-

-

-

-

-

-

-

Proceeds from issuance of long-term debt, net of original issue discount of $11,400

-

0

0

0

43,600

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Payments on long-term debt

-

-

-

-

-

-

-

-

-

-

-

-

-

0

3,691

0

2,633

-

-

-

-

-

-

-

-

Payment of deferred financing costs

-

0

0

0

2,936

700

0

0

261

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from sale of common stock, net of transaction costs

-

-

-

-

-

5,634

347

7,470

3,514

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Payments of withholdings on shares withheld for income taxes

1,151

647

55

110

864

0

4

1

86

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Payment of deferred financing costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-14

1,607

125

-

-

-

-

Proceeds from option exercises

130

3,451

1,458

908

186

757

31

962

65

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash provided by financing activities

-

-

-

-

-

-

374

8,431

3,232

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from notes payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

175

Net cash provided by/(used in) financing activities, continuing operations

-1,021

-

-

-

39,986

-

-

-

-

-

-

-

-

40,491

9,643

3,615

-2,073

-8,491

7,039

48,317

-125

-3

0

-168

30,708

Net increase in cash and cash equivalents from continuing operations

1,897

-

-

-

27,023

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Discontinued Operations:
Cash flows used in operating activities

-1,172

-

-

-

-14,197

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cash flows used in investing activities

-

-

-

-

-359

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cash flows used in financing activities

-

-

-

-

-5,000

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net decrease in cash and cash equivalents from discontinued operations

-1,172

-

-

-

-19,556

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net decrease in cash and cash equivalents

-

-

-

-

-

-

-

2,627

-14,700

-

3,075

-10,757

-44,998

39,731

9,907

-72

-4,862

-8,496

12,588

-903

-3,091

-4,221

-3,928

-2,072

29,892

Supplemental disclosure of cash flow information:
Cash paid for interest

3,693

3,794

3,957

3,910

2,734

1,920

1,839

1,829

2,546

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Conversion of notes payable and accrued interest into common stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

12,274

Conversion of Series A and accrued dividends into common stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,181

0

0

5,968

Cash paid for interest

-

-

-

-

-

-

-

-

-

-

-

-

1,026

1,038

1,106

1,158

1,215

-

-

-

-

-

-

-

-

Unrealized loss on available-for-sale securities

-

-

-

-

-

-

-

-

-

-

-

-

57

-

-

-

-

-

-

-

-

-

-

-

-

Purchase of property, plant and equipment included in accrued expenses and accounts payable

702

267

-236

-881

1,138

-884

2,677

259

249

-539

389

148

237

-

-

-

-

-

-

-

-

-

-

-

-

Retirement of fully depreciated property, plant and equipment

-

-

-

-

-

-

-

-

30

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Common stock issued in connection with equity facility

-

0

0

0

301

0

0

0

357

-

-

-

-

-

-

-

-

0

0

0

284

-

-

-

-